"You are incredibly prescient!" I woke up to those words from a former colleague on Jan. 19, 2022: the bombshell announcement that the Chief Science Officer of pharma giant GSK, where I worked until recently, will become the CEO at the new, $3 BILLION longevity science company Altos (presumably also funded by Amazon's Jeff Bezos.) Big Pharma is at long last embracing Longevity Science. The corollary: longevity science is entering Mainstream (with capital "M") But let me backtrack... The Decade of Longevity Science When Harvard professor David Sinclair declared the 2020's to be the " decade of the paradigm shift about age reversal ", one could perhaps be dismissive of it as just an outburst of enthusiasm... But in the past couple of years, we're seeing strong evidence that his forecast is right on the mark! While I worked at GlaxoSmithKline - a giant, top-10, pharma company - I vigorously advocated forming a Longevity Science dept., and sp